We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Artificial Intelligence Detects Undiagnosed Liver Disease from Echocardiograms

By HospiMedica International staff writers
Posted on 04 Mar 2025

Echocardiography is a diagnostic procedure that uses ultrasound to visualize the heart and its associated structures. More...

This imaging test is commonly used as an early screening method when doctors suspect a patient may have cardiovascular disease. A typical echocardiogram may contain more than 50 video clips, with some showing images of the liver. People with heart disease often develop chronic liver conditions, making it difficult to differentiate between primary liver disease and liver injury resulting from heart disease. It’s estimated that 4.5 million individuals have been diagnosed with liver disease, although many more may have undiagnosed steatotic liver disease, previously known as fatty liver disease. Now, a new artificial intelligence (AI) program can detect chronic liver disease from videos captured during an echocardiogram. This deep-learning model aids doctors in identifying liver disease that might otherwise go unnoticed, leading to timely follow-up testing.

Researchers at Cedars-Sinai (Los Angeles, CA, USA) trained an AI system to analyze patterns in over 1.5 million echocardiogram videos. The AI program, called EchoNet-Liver, was able to detect cirrhosis (scarring of the liver) and steatotic liver disease by examining liver images captured during echocardiograms. This technology builds upon the earlier-developed EchoNet, which identifies and analyzes patterns in echocardiogram images. The team compared the deep-learning model's predictions to diagnoses made using abdominal ultrasounds or MRI images. According to a study published in NEJM AI, the AI model's accuracy was comparable to that of traditional imaging methods analyzed by radiologists. The next phase of research involves testing EchoNet-Liver in studies that track patients' health over time.

“These novel findings exemplify how AI models are helping us to augment clinical diagnostics at a body-systems level instead of just individual organs,” said Sumeet Chugh, MD, director of the Division of Artificial Intelligence in Medicine at Cedars-Sinai.


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Infant Resuscitator
Easypuff
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.